Dementia: The neurochemical basis of putative transmitter orientated therapy
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 52 (3) , 423-443
- https://doi.org/10.1016/0163-7258(91)90035-k
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Cholinergic grafts, memory and ageingTrends in Neurosciences, 1991
- Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's diseaseThe Lancet, 1991
- Hypothesis linking plasticity, vulnerability and nerve growth factor to basal forebrain cholinergic neuronsInternational Journal of Geriatric Psychiatry, 1990
- Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularisJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivoLife Sciences, 1990
- Decreased levels of protein kinase C in Alzheimer brainBrain Research, 1988
- Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor siteNeuroscience Letters, 1988
- VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by alzheimer's disease/senile dementia of the Alzheimer typeNeurobiology of Aging, 1988
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983